Results 231 to 240 of about 733,442 (314)
Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa. [PDF]
Kibuuka E +3 more
europepmc +1 more source
Objective Mutations in TARDBP (encoding TDP‐43) are associated with the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and include familial missense mutations where there are a lack of models and mechanisms examining how they are pathogenic.
Ziyaan A. Harji +10 more
wiley +1 more source
Annual Course / From Then to Now: The Evolving Spectrum of Epilepsy Care. [PDF]
McKee HR +18 more
europepmc +1 more source
Persisting Transglutaminase 6 Antibodies in Neurological Gluten‐Related Disorders
Objective Gluten‐related autoimmunity can cause neurological disease, although the best way to diagnose and monitor such patients is unclear. Serological testing for antibodies against transglutaminase 6 (TG6) has been proposed; however, this is not widely available in clinical practice.
Iain D. Croall +6 more
wiley +1 more source
Prognosis of people with focal epilepsy treated with anti-seizure medications (ASMs): a narrative review of current evidence and future directions. [PDF]
Barnard S +4 more
europepmc +1 more source
Sudden unexpected death in epilepsy, incidence, circumstances and risk factors
Ólafur Sveinsson
openalex
Is it possible to sneeze your way out of epilepsy? [PDF]
Karl O. Nakken, Mia Tuft
openalex +1 more source
A Growth Chart for KBG Syndrome
American Journal of Medical Genetics Part A, EarlyView.
Karen J. Low +6 more
wiley +1 more source
Objective Myotonic dystrophy type 1 (DM1) is a highly variable, multisystemic genetic disorder caused by a CTG repeat expansion in the 3′ untranslated region of DMPK. Toxicity is exerted by repeat‐containing DMPK transcripts that sequester muscleblind‐like (MBNL) proteins and lead to deleterious yet predictable changes in alternative splicing.
Samuel T. Carrell +3 more
wiley +1 more source

